BUSINESS
-
The World Corporate Chess Championship will crown ‘the smartest company in the world’
The fierce rivalry between tech and finance brainiacs will come to a head this weekend in the finals of a…
Read More » -
Uniswap Labs acquires Crypto: The Game—‘It’s ballooned into this 24/7 crypto reality show’
The second season of Crypto: The Game (CTG) sold out in 13 minutes. Thousands of fans scrambled for one of…
Read More » -
‘Full House’ home for sale for $6.5 million
Been dreaming of owning the Tanner’s house from Full House since Michelle was a toddler? You got it, dude—if you’ve…
Read More » -
Verge Genomics CEO: Biotech works better when employees can express fears, vulnerabilities
Alice Zhang is CEO and cofounder of Verge Genomics. I started my biotech company Verge Genomics out of graduate school…
Read More » -
Michael Dell’s net worth sinks the most in a single day, falling by $11.7 billion after shares of his company suffer record selloff on weak revenue
Michael Dell’s wealth tumbled the most in a single day after the computer company he founded posted results that disappointed…
Read More » -
Being a millionaire is no longer the endgame for most Americans
Fewer than 20% of Americans, across age groups, equate financial success with being a millionaire, per Bankrate’s 2024 Financial Success…
Read More » -
U.S. vows to support Israel’s defense as Iran launches drone attack
Iran launched dozens of drones toward Israel late Saturday, Israeli and Iranian officials confirmed, on an unprecedented revenge mission that…
Read More » -
Authorities probe a second fatal Ford EV crash that may have involved its partially automated driving system
The National Transportation Safety Board is investigating a March crash near Philadelphia that killed two people and involved a Ford…
Read More » -
‘Carbon colonialism’ in Africa meets resistance
Matthew Walley’s eyes sweep over the large forest that has sustained his Indigenous community in Liberia for generations. Even as…
Read More » -
ALS drug will be pulled from US market after study showed patients didn’t benefit
The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the…
Read More »